Abstract Here we describe the fecal microbiome of laboratory beagles in a non-invasive and humane experiment designed to contrast in vivo versus invitro bioequivalence in response to antiparasitic drug administration. The experiment provided a unique opportunity to describe the fecal microbiota of dogs in an experimental setting prior to their adoption. These data are contributed as a resource for the scientific community by the Center for Veterinary Medicine (CVM) of the U.S. Food and Drug Administration (FDA).

Fecal microbiomes of laboratory beagles receiving antiparasitic formulations in an experimental setting